Literature DB >> 16546471

Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial.

Jian Wu1, Jun Oka, Mitsuru Higuchi, Izumi Tabata, Toshiya Toda, Maiko Fujioka, Noriyuki Fuku, Takanori Teramoto, Takenori Okuhira, Tomomi Ueno, Shigeto Uchiyama, Kouji Urata, Kazuhiko Yamada, Yoshiko Ishimi.   

Abstract

Cooperative effects of isoflavones and exercise on bone and lipid metabolism have been exhibited in estrogen-deficient animals; however, results from clinical trials have not been published. In this study, we determined the effects of isoflavone intake and walking and their interaction on bone and lipid metabolism in postmenopausal women over 24 weeks. The bioavailability and metabolism of isoflavones (daidzein in particular) were also examined to clarify the mechanism of their bone-protective effects in humans. One hundred twenty-eight subjects were randomly assigned to 4 groups: placebo; placebo combined with walking (3 times per week); isoflavone intake (75 mg of isoflavones conjugates per day); and isoflavone combined with walking. The subjects were classified by equol status (producers or nonproducers) as identified using production of equol from daidzein in fecal culture. Bone mineral density (BMD), body composition, and serum concentrations of isoflavones were assessed. Serum high-density lipoprotein cholesterol concentration significantly increased (6.1%, P = .03), and fat mass in the whole body significantly decreased (-4.3%, P = .0003) from the baseline in the combined intervention group. There were no significant differences in BMD between baseline and postintervention in any of the treatment groups. However, the percent changes in BMD in equol producers were -0.53% and +0.13% in the sub-whole body and total hip, respectively. This was significantly different compared with -1.35 and -1.77 for the sub-whole body and total hip, respectively, in nonproducers in the isoflavone group (P = .049 and .040, respectively). The mean serum equol concentration was significantly higher in equol producers than in nonproducers in the isoflavone groups, but not in the placebo group. The combination of isoflavones and exercise exhibited favorable effects on serum lipid and body composition of postmenopausal women. The findings of this study suggest that the preventive effects of isoflavones on bone loss depend on the individual's intestinal flora for equol production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546471     DOI: 10.1016/j.metabol.2005.10.002

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  30 in total

1.  Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.

Authors:  Silvina Levis; Nancy Strickman-Stein; Daniel R Doerge; Jeffrey Krischer
Journal:  Contemp Clin Trials       Date:  2010-03-15       Impact factor: 2.226

2.  Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone loss.

Authors:  Connie M Weaver; Leecole L Legette
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

Review 3.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

4.  Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States.

Authors:  Charlotte Atkinson; Katherine M Newton; Mellissa Yong; Frank Z Stanczyk; Kim C Westerlind; Lin Li; Johanna W Lampe
Journal:  Metabolism       Date:  2012-07-21       Impact factor: 8.694

Review 5.  Effect of Soy and Soy Isoflavones on Obesity-Related Anthropometric Measures: A Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials.

Authors:  Masoumeh Akhlaghi; Morteza Zare; Fatemeh Nouripour
Journal:  Adv Nutr       Date:  2017-09-15       Impact factor: 8.701

6.  Equol production changes over time in pre-menopausal women.

Authors:  Adrian A Franke; Jennifer F Lai; Ian Pagano; Yukiko Morimoto; Gertraud Maskarinec
Journal:  Br J Nutr       Date:  2011-09-16       Impact factor: 3.718

Review 7.  Nutritional genomics, polyphenols, diets, and their impact on dietetics.

Authors:  Stephen Barnes
Journal:  J Am Diet Assoc       Date:  2008-11

8.  Is equol the key to the efficacy of soy foods?

Authors:  Johanna W Lampe
Journal:  Am J Clin Nutr       Date:  2009-04-08       Impact factor: 7.045

9.  Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats.

Authors:  Leecole L Legette; Berdine R Martin; Mohammad Shahnazari; Wang-Hee Lee; William G Helferich; Junqi Qian; David J Waters; Alireza Arabshahi; Stephen Barnes; Jo Welch; David G Bostwick; Connie M Weaver
Journal:  J Nutr       Date:  2009-08-26       Impact factor: 4.798

10.  Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures.

Authors:  Takuya Ohtomo; Mariko Uehara; José Luis Peñalvo; Herman Adlercreutz; Shin-ichi Katsumata; Kazuharu Suzuki; Ken Takeda; Ritsuko Masuyama; Yoshiko Ishimi
Journal:  Eur J Nutr       Date:  2008-07-11       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.